Clinic study of therapeutic effect of chronic hepatitis B patients treated with interferon α
Wang Jun
Abstract
Wang Jun
Abstract
Objective To study the therapeutic effect of α-2b interferon(IFN-α-2b) treating chronic hepatitis B(CHB).Methods One hundred and forty CHB cases were divided into 2 groups: 83 cases in IFN-α-2b treatment group,and 40 cases in liver-protective group.The liver function,change of hepatitis B virus marker and side-effects of α-2b interferon were observed. Results In the treatment group,the complete response rate,the ALT recovery rate,HBeAg negative rate and HBV-DNA negative rate were significantly higher than those in liver-protective group at the end of the treatment. In the treatment group,better therapeutic effect revealed in higher ALT Level and HBV-DNA≤106 copies/mL before treatment.The therapeutic effect might correlate with gender and age.The side-effects of IFN-α-2b could recover quickly without special treatment.Conclusion IFN-α-2b may inhibit the replication of HBV,improve liver functions,and speed the spontaneous seroconvesrsion of HBeAg and HBV-DNA,and is one of the effective and safety medicines for treating CHB.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the therapeutic effect of α-2b interferon(IFN-α-2b) treating chronic hepatitis B(CHB).Methods One hundred and forty CHB cases were divided into 2 groups: 83 cases in IFN-α-2b treatment group,and 40 cases in liver-protective group.The liver function,change of hepatitis B virus marker and side-effects of α-2b interferon were observed. Results In the treatment group,the complete response rate,the ALT recovery rate,HBeAg negative rate and HBV-DNA negative rate were significantly higher than those in liver-protective group at the end of the treatment. In the treatment group,better therapeutic effect revealed in higher ALT Level and HBV-DNA≤106 copies/mL before treatment.The therapeutic effect might correlate with gender and age.The side-effects of IFN-α-2b could recover quickly without special treatment.Conclusion IFN-α-2b may inhibit the replication of HBV,improve liver functions,and speed the spontaneous seroconvesrsion of HBeAg and HBV-DNA,and is one of the effective and safety medicines for treating CHB.
Key concepts: Medicine, HBeAg, Therapeutic effect, Interferon, Internal medicine, Gastroenterology, Chronic hepatitis, Liver function